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Unicuspid aortic valve (UAV) is a rare congenital mal-formation, seen in approximately 0.02% of patientsreferred for echocardiography but in as many as 4% to6% of patients undergoing operations for “pure aortic
stenosis.”1,2 Of the two pathologic types, the acommisural and the
unicommisural, the latter predominates in both adult and pediatric
populations (Figure 1). Aortic dilatation is known to be frequent in
this condition, but limited information exists.
Patients
Between January 1, 2002, and January 1, 2005, 12 patients with
UAV, conﬁrmed by both intraoperative transesophageal echocar-
diography and surgical inspection, underwent valve surgery at one
institution (1.8% of 671 cases). The transesophageal echocardio-
gram was reviewed for the following: aortic valve area, diameter
of the ascending aorta, maximal and mean transaortic valve gra-
dient, grade of aortic insufﬁciency, and left ventricular ejection
fraction.
Eleven (92%) of the patients were male. Age at surgery ranged
from 24 to 58 years (mean: 44  9 years [1 SD]). The presenting
symptoms were angina and shortness of breath in 3 (25%), angina
only in 2 (17%), and shortness of breath only in 2 (17%). Two
patients (17%) were free of symptoms. The remaining patient had
monocular blindness (emboli to the retinal artery) but had no
cardiac symptoms.
Operative Technique and Findings
Valve replacement was performed with standard techniques on 11
patients. In the 12th patient, a 24-year-old man, a ﬂexible noncal-
ciﬁed valve was preserved. Mechanical valves were used in 2
patients and bovine pericardial bioprostheses in 9 patients. The
ascending aorta was replaced in 7 patients. Additional procedures
were performed on some patients (Table 1).
Ascending aortic dilatation (40 mm) was found in 6 patients
(50%), and all underwent replacement of the ascending aorta. In
the 4 patients with signiﬁcant aortic insufﬁciency, the aorta was
also replaced. Ascending aortic size was associated with younger
age at operation (P .02). Each patient older than 47 years had an
aortic size less than 40 mm, whereas in the younger group 86%
(6/7) had an aortic size greater than 45 mm.
An “abnormal” pattern of calciﬁcation was noted in 11 patients
with large volume and extension either into the proximal aorta or,
in 6 patients, into the interventricular septum just lateral to its
membranous component.
There were no in-hospital or late deaths. Complications in-
cluded pleural or pericardial effusion in 7 patients (58%) and
third-degree heart block in 2 patients (17%).
Discussion
We found UAVs in 1.8% of patients undergoing replacement,
which is lower than ﬁgures from other reports (4%-6%) based on
specimen examination in adult patients with isolated aortic valve
stenosis.2 We included all patients having aortic valve replace-
ment, including those who had any concomitant procedure. Dif-
ferences in incidence may be due to difﬁculty in discriminating
this condition from a severely calciﬁed bicuspid valve. There are
anatomic clues that can aid in surgical diagnosis, including the
shape of the leaﬂet attachment zone.
The typical age presentation in this series was the ﬁfth decade
(7/12 patients). Although a few recent series have noted a similar
pattern, with patients presenting in their ﬁfth or sixth decade of
life,3 the preponderance of reports suggested a much earlier pre-
sentation, in the third decade.1
This report is the ﬁrst to document the relationship of
pathologic dilatation of the ascending aorta and age at presenta-
tion. This separated our patients into two distinct clinical groups.
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Figure 1. Severely calciﬁed, unicommisural UAV.
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The relationship was sharp, and there was a breakpoint at age 47
(Figure 2), suggesting two different patterns of this disease. The
older patients appeared to have a less aggressive form, with de-
layed presentation of symptoms and without aortic dilatation. In
contrast, the aggressive form of unicuspid disease was associated
with early symptoms and aortic involvement. The latter group may
have similar pathologic characteristics to the much more common
entity of bicuspid aortic valve and ascending aortic dilatation.
The prevalence of ascending aortic dilatation in the aggres-
sive form of presentation leads to uniform ascending aortic
replacement. This approach was taken from the experience with
bicuspid disease, and our observations suggest that with older
age subsequent dilatation is uncommon in the less aggressive
form.4
An important observation is the abundance of calciﬁcation
found in almost all patients. Particularly important for the surgeon
is the 50% incidence of calciﬁcation extending into the interven-
tricular septum, increasing the possibility of conduction system
damage, which did occur in 2 of these patients. The debridement
of calcium in preparation for valve implantation was undoubtedly
the injuring mechanism in these patients and suggests caution in
subvalvular debridement.
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TABLE 1. Twelve patients with UAV and their characteristics
Age (y)/sex AVR/replacement of aorta/other operation AVA AA max mean AI LVEF
45, M AVR/CABG 0.73 35 66 42 1 55
24, M Ascending  hemiarch 1.2 53 45 27 1 64
49, M AVR 0.5* 33 110* — 2 60
47, M AVR/ascending/septal myomectomy 1.1 50 103 63 4 74
32, M AVR/ascending 0.7* 45 122* 60* 2 58
58, M AVR 1.1 36 77 50 1 62
48, M AVR/ascending  root 1.2 37 60 — 4 55
49, F AVR/septal myomectomy 0.7 30 81 46 1 75
46, M AVR/ascending 1.2 50 29 16 2 62
52, M AVR/septal myomectomy 1.2 35 135 62* 1 86
42, M AVR/ascending — 50 77† 47† 3 60
37, M AVR/ascending  hemiarch  root/CABG 0.7 46 22 9 3 40
Avg 44.42 1.01 40.33 68.67 41.11 2.08 62.58
SD 9.04 0.22 7.58 34.16 17.44 1.16 11.66
AVR, Aortic valve replacement; CABG, coronary artery bypass graft; AVA, aortic valve area (mm); AA, Ascending aorta size (mm); max and mean, maximal and
mean transaortic valve gradient; AI, aortic insufﬁciency (1 none, 2 mild, 3 moderate, 4 severe); LVEF, left ventricular ejection fraction (%); Avg, average;
SD, standard deviation. *Most recent preoperative transesophageal echocardiogram. †Most recent postoperative transesophageal echocardiogram.
Figure 2. Aortic size at presentation versus age. This depicts a
series of 12 patients undergoing replacement of UAV. The squares
represent patients who had concomitant replacement of the as-
cending aorta; the circles represent patients in whom the as-
cending aorta was not replaced. There appear to be two distinct
clinical presentations, earlier in life with aortic enlargement and
later in life without.
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